Search research articles
Contact Us
Filters
Showing results (291-300 of 304) with videos related to
Page
of 31
Sort By:
Oncology
|
June 9, 2012
Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience
Akihiro Suzuki, Lianchun Xiao, Takashi Taketa, et al.
Nature Photonics
|
June 19, 2018
Large magneto-optical Kerr effect and imaging of magnetic octupole domains in an antiferromagnetic metal
Tomoya Higo, Huiyuan Man, Daniel B Gopman, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
June 23, 2011
Composition controlled spin polarization in Co(1-x)Fe(x)S(2) alloys
C Leighton, M Manno, A Cady, et al.
Translational Psychiatry
|
January 20, 2016
Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue
C-Y Lai, S-Y Lee, E Scarr, et al.
Scientific Reports
|
May 28, 2021
Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
Shannon Wongvibulsin, Nishadh Sutaria, Suraj Kannan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 26, 2015
CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses
Baoying Liu, Ashwin Dhanda, Sima Hirani, et al.
Genes, Brain, and Behavior
|
July 19, 2017
Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia
S-H Wang, P-C Hsiao, L-L Yeh, et al.
JCO Precision Oncology
|
June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy
Jeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2013
Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug
Md L T Vieira, B Kirby, I Ragueneau-Majlessi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 304) with videos related to
Sort By:
Page
of 31
Oncology
|
June 9, 2012
Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience
Akihiro Suzuki, Lianchun Xiao, Takashi Taketa, et al.
Nature Photonics
|
June 19, 2018
Large magneto-optical Kerr effect and imaging of magnetic octupole domains in an antiferromagnetic metal
Tomoya Higo, Huiyuan Man, Daniel B Gopman, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
June 23, 2011
Composition controlled spin polarization in Co(1-x)Fe(x)S(2) alloys
C Leighton, M Manno, A Cady, et al.
Translational Psychiatry
|
January 20, 2016
Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue
C-Y Lai, S-Y Lee, E Scarr, et al.
Scientific Reports
|
May 28, 2021
Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
Shannon Wongvibulsin, Nishadh Sutaria, Suraj Kannan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 26, 2015
CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses
Baoying Liu, Ashwin Dhanda, Sima Hirani, et al.
Genes, Brain, and Behavior
|
July 19, 2017
Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia
S-H Wang, P-C Hsiao, L-L Yeh, et al.
JCO Precision Oncology
|
June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy
Jeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2013
Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug
Md L T Vieira, B Kirby, I Ragueneau-Majlessi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
Page
of 31